AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 104 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $9,352,000 | +20.8% | 994,916 | -1.7% | 0.00% | +33.3% |
Q2 2020 | $7,739,000 | +28.3% | 1,011,673 | +3.7% | 0.00% | 0.0% |
Q1 2020 | $6,031,000 | -45.9% | 975,857 | +6.5% | 0.00% | -25.0% |
Q4 2019 | $11,151,000 | -11.8% | 916,283 | -16.3% | 0.00% | -20.0% |
Q3 2019 | $12,645,000 | +15.4% | 1,094,692 | -0.2% | 0.01% | +25.0% |
Q2 2019 | $10,960,000 | -22.5% | 1,097,195 | -0.1% | 0.00% | -33.3% |
Q1 2019 | $14,141,000 | -15.2% | 1,097,961 | -0.0% | 0.01% | -25.0% |
Q4 2018 | $16,679,000 | -24.1% | 1,097,994 | -0.1% | 0.01% | 0.0% |
Q3 2018 | $21,972,000 | +1.0% | 1,098,585 | -1.5% | 0.01% | -11.1% |
Q2 2018 | $21,757,000 | -5.5% | 1,115,731 | -2.3% | 0.01% | -10.0% |
Q1 2018 | $23,017,000 | +50.9% | 1,142,295 | -0.8% | 0.01% | +66.7% |
Q4 2017 | $15,252,000 | -28.2% | 1,151,082 | -0.0% | 0.01% | -33.3% |
Q3 2017 | $21,240,000 | -5.0% | 1,151,226 | -5.3% | 0.01% | -10.0% |
Q2 2017 | $22,361,000 | -3.3% | 1,215,249 | +18.5% | 0.01% | -9.1% |
Q1 2017 | $23,129,000 | +63.6% | 1,025,673 | +152.4% | 0.01% | +57.1% |
Q4 2016 | $14,140,000 | +44.3% | 406,303 | +1.6% | 0.01% | +40.0% |
Q3 2016 | $9,799,000 | +3.1% | 399,796 | +0.6% | 0.01% | 0.0% |
Q2 2016 | $9,503,000 | +2.2% | 397,296 | 0.0% | 0.01% | -16.7% |
Q1 2016 | $9,296,000 | -22.6% | 397,296 | -0.1% | 0.01% | -14.3% |
Q4 2015 | $12,010,000 | -22.4% | 397,816 | +2.2% | 0.01% | -30.0% |
Q3 2015 | $15,470,000 | -42.7% | 389,381 | -0.5% | 0.01% | -41.2% |
Q2 2015 | $27,017,000 | +25.2% | 391,223 | -0.9% | 0.02% | +21.4% |
Q1 2015 | $21,576,000 | +28.0% | 394,713 | -0.2% | 0.01% | +27.3% |
Q4 2014 | $16,857,000 | +33.6% | 395,511 | 0.0% | 0.01% | +22.2% |
Q3 2014 | $12,619,000 | +56.2% | 395,511 | +1.4% | 0.01% | +50.0% |
Q2 2014 | $8,080,000 | +17.7% | 389,980 | +9.9% | 0.01% | +20.0% |
Q1 2014 | $6,866,000 | -20.3% | 354,869 | +0.0% | 0.01% | -28.6% |
Q4 2013 | $8,610,000 | +8.9% | 354,777 | -3.6% | 0.01% | 0.0% |
Q3 2013 | $7,903,000 | -1.0% | 367,902 | +2.6% | 0.01% | -12.5% |
Q2 2013 | $7,983,000 | – | 358,753 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,921,550 | $81,254,000 | 4.00% |
Palo Alto Investors LP | 1,614,536 | $33,453,000 | 2.49% |
Ghost Tree Capital, LLC | 100,000 | $2,072,000 | 1.46% |
March Altus Capital Management LP | 146,418 | $3,034,000 | 1.11% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 296,458 | $6,143,000 | 0.98% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,339 | $20,706,000 | 0.83% |
Visium Asset Management, LP | 2,070,870 | $42,908,000 | 0.67% |
AlphaOne Investment Services, LLC | 97,448 | $2,019,000 | 0.54% |
CONTINENTAL ADVISORS LLC | 57,438 | $1,190,000 | 0.28% |
Tamarack Capital Management, LLC | 64,080 | $1,222,000 | 0.25% |